肝细胞癌组织学亚型的MRI特征:与组织学、遗传学和分子生物学分类的相关性
本文综述肝细胞癌(HCC)组织学异质性及其与钆增强动态肝脏MRI表现的相关性。基于转录组学分类,讨论低增殖类(脂肪性肝炎型HCC、CTNNB1突变型HCC)和高增殖类(巨梁状-团块型HCC、硬化型HCC、CK19阳性HCC)以及肉瘤样HCC和纤维板层型HCC的影像-病理-分子特征。影像特征可能最终实现无创诊断并作为预测预后、分子特征和治疗反应的生物标志物。
要点
- HCC可按转录组谱分为多种亚型,影像表型与组织学、遗传和分子特征间存在相关性证据。
- 低增殖类包括脂肪性肝炎型HCC和CTNNB1突变型HCC;高增殖类包括巨梁状-团块型HCC、硬化型HCC和CK19阳性HCC。
- 影像特征可能最终实现无创诊断和亚型表征,作为预测预后、分子特征和治疗反应的生物标志物。
核心结论
- HCC组织学、遗传和蛋白表达异质,影像表型与各亚型的组织学、分子和遗传特征间相关性证据日增;影像特征可能最终实现无创诊断和亚型表征,作为预测预后、分子特征和治疗反应的生物标志物;精准医学时代需多学科努力建立整合影像与临床的各HCC亚型诊断体系。
研究设计与样本
- 综述,讨论钆增强动态肝脏MRI表现与HCC组织学异质性的相关性,并依据转录组谱概述HCC亚型分类,描述低增殖类(脂肪性肝炎型HCC、CTNNB1突变型HCC)和高增殖类(巨梁状-团块型HCC、硬化型HCC、CK19阳性HCC)以及肉瘤样HCC和纤维板层型HCC的组织学、遗传和分子特征。
临床应用与阅片要点
- 作者认为,进一步研究HCC亚型的影像学特征可能最终实现无创诊断,并作为预测预后、分子特征和治疗反应的生物标志物。
- 作者认为,精准医学时代需多学科努力建立整合影像与临床的各HCC亚型诊断体系。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
HCC is a heterogeneous group of tumors in terms of histology, genetic aberration, and protein expression. Advancements in imaging techniques have allowed imaging diagnosis to become a critical part of managing HCC in the clinical setting, even without pathologic diagnosis. With the identification of many HCC subtypes, there is increasing correlative evidence between imaging phenotypes and histologic, molecular, and genetic characteristics of various HCC subtypes. In this review, current knowledge of histologic heterogeneity of HCC correlated to features on gadolinium-enhanced dynamic liver MRI will be discussed. In addition, HCC subtype classification according to transcriptomic profiles will be outlined with descriptions of histologic, genetic, and molecular characteristics of some relatively well-established morphologic subtypes, namely the low proliferation class (steatohepatitic HCC and CTNNB1-mutated HCC) and the high proliferation class (macrotrabecular-massive HCC (MTM-HCC), scirrhous HCC, and CK19-positive HCC). Characteristics of sarcomatoid HCC and fibrolamellar HCC will also be discussed. Further research on radiological characteristics of HCC subtypes may ultimately enable non-invasive diagnosis and serve as a biomarker in predicting prognosis, molecular characteristics, and therapeutic response. In the era of precision medicine, a multidisciplinary effort to develop an integrated radiologic and clinical diagnostic system of various HCC subtypes is necessary. KEY POINTS: • HCC is a heterogeneous group of tumors in terms of histology, genetic aberration, and protein expression, which can be divided into many subtypes according to transcriptome profiles. • There is increasing evidence of a correlation between imaging phenotypes and histologic, genetic, and molecular biologic characteristics of various HCC subtypes. • Imaging characteristics may ultimately enable non-invasive diagnosis and subtype characterization, serving as a biomarker for predicting prognosis, molecular characteristics, and therapeutic response.
引用
- Yoon JK, Choi JY, Rhee H, et al. MRI features of histologic subtypes of hepatocellular carcinoma: correlation with histologic, genetic, and molecular biologic classification. Eur Radiol. 2022. PMID: 35258675. doi:10.1007/s00330-022-08643-4
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。